Results 111 to 120 of about 23,896 (206)

Unmasking EGPA with near fatal diffuse alveolar haemorrhage in severe eosinophilic asthma under treatment with benralizumab: a case report. [PDF]

BMC Pulm Med
Drick N, Kaireit TF, Ruwisch J, Schallhorn S, Bauersachs J, Schenk H, Hoeper MM, Witte T, Seeliger B.   +8 more
europepmc   +1 more source

Can Coexisting Allergic Rhinitis in Patients with Severe Eosinophilic Asthma Be a Prognostic Factor for Efficacy of Biological Therapy? Analysis of Eosinophilic Involvement. [PDF]

J Clin Med
Jura-Szołtys E, Glück J, Klimek L, Gawlik R.   +3 more
europepmc   +1 more source

Real-World Effectiveness Following Benralizumab Use in Patients with Severe Eosinophilic Asthma in Romania: A Retrospective Cohort Study (BREEZE). [PDF]

J Clin Med
Toma CL, Teodorescu G, Mihălţan FD, Frent S, Ali S, Trenchea M, Constantin AA.   +6 more
europepmc   +1 more source

Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial

, 2018
Richard Russell, Latifa Chachi, J. Mark FitzGerald, Vibeke Backer, Ronald Olivenstein, Ingrid Louise Titlestad, Charlotte Suppli Ulrik, Timothy Harrison, Dave Singh, Rekha Chaudhuri, Brian Leaker, Lorcan McGarvey, Salman Siddiqui, Millie Wang, Martin Braddock, Lars H. Nordenmark, David Cohen, Himanshu Parikh, Gene Colice, Christopher E. Brightling, Michel Laviolette, Tina Skjold, Læge Carl Nielsen, Peter Howarth   +23 more
openalex   +2 more sources

Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a <i>post hoc</i> analysis of the ANANKE study. [PDF]

ERJ Open Res
Senna G, Brussino L, Aliani M, Altieri E, Bracciale P, Caiaffa MF, Cameli P, Canonica GW, Caruso C, Centanni S, De Michele F, Del Giacco S, Di Marco F, Malerba L, Menzella F, Pelaia G, Rogliani P, Romagnoli M, Schino P, Schroeder JW, Vultaggio A, D'Amato M, Caminati M.   +22 more
europepmc   +1 more source

Determinants of Clinical Remission in Dupilumab-Treated Severe Eosinophilic Asthma: A Real-World Retrospective Study. [PDF]

Biomedicines
Bonato M, Favero E, Savoia F, Drigo M, Rizzato S, Orzes E, Senna G, Romagnoli M.   +7 more
europepmc   +1 more source

Relationship Between Benralizumab Exposure and Efficacy for Patients With Severe Eosinophilic Asthma [PDF]

, 2019
Yen Lin Chia, Yan Li, Binbing Yu, Bing Wang, Peter Barker, Mitchell Goldman, Lorin Roskos   +6 more
openalex   +1 more source

Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2. [PDF]

Clin Exp Allergy
Penz E, Rothe T, Dupont L, Tran TN, Menzies-Gow A, Shavit A, Cohen D, Plate T, Kayaniyil S, Herreman A, Schuoler C, Emmanuel B, Lommatzsch M.   +12 more
europepmc   +1 more source

One Year Real Life Data Of Patients With Severe Eosinophilic Asthma Treated With Mepolizumab

Şeyma Özden, Fatma Merve Tepetam, Özge Atik, Sinan Arslan   +3 more
openalex   +1 more source

Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: Involvement in patients with severe eosinophilic asthma [PDF]

, 2015
Marie-Chantal Larose, Jamila Chakir, Anne‐Sophie Archambault, Philippe Joubert, Véronique Provost, Michel Laviolette, Nicolas Flamand   +6 more
openalex   +1 more source